These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 9147146)
1. Hyperthermic modulation of resistance to cis-diamminedichloroplatinum (II) in human larynx carcinoma cells. Beketić-Oresković L; Jaksić M; Oresković S; Osmak M Int J Hyperthermia; 1997; 13(2):205-14. PubMed ID: 9147146 [TBL] [Abstract][Full Text] [Related]
2. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance. Beketić-Oresković L; Osmak M; Jaksić M Neoplasma; 1994; 41(3):163-9. PubMed ID: 7935985 [TBL] [Abstract][Full Text] [Related]
3. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): cross-resistance patterns. Beketić-Oresković L; Osmak M Neoplasma; 1994; 41(3):171-6. PubMed ID: 7935986 [TBL] [Abstract][Full Text] [Related]
4. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance. Sharp SY; Rogers PM; Kelland LR Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070 [TBL] [Abstract][Full Text] [Related]
5. Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline. Herman TS; Teicher BA; Cathcart KN; Kaufmann ME; Lee JB; Lee MH Cancer Res; 1988 Sep; 48(18):5101-5. PubMed ID: 3409235 [TBL] [Abstract][Full Text] [Related]
6. Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Wallner KE; DeGregorio MW; Li GC Cancer Res; 1986 Dec; 46(12 Pt 1):6242-5. PubMed ID: 3779644 [TBL] [Abstract][Full Text] [Related]
7. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin. Bergs JW; Haveman J; Ten Cate R; Medema JP; Franken NA; Van Bree C Oncol Rep; 2007 Jul; 18(1):219-26. PubMed ID: 17549371 [TBL] [Abstract][Full Text] [Related]
8. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology. Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906 [TBL] [Abstract][Full Text] [Related]
9. Collateral resistance or sensitivity of human larynx carcinoma HEp2 cells resistant to cis-dichlorodiammineplatinum (II) or vincristine sulfate. Osmak M Neoplasma; 1992; 39(3):197-202. PubMed ID: 1528326 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a cisplatin-resistant subline of murine RIF-1 cells and reversal of drug resistance by hyperthermia. Mansouri A; Henle KJ; Benson AM; Moss AJ; Nagle WA Cancer Res; 1989 May; 49(10):2674-8. PubMed ID: 2713851 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of cross-resistance between responses to cisplatin, hyperthermia, and radiation in human glioma cells and eight clones selected for cisplatin resistance. Raaphorst GP; Wilkins DE; Mao JP; Miao JC; Ng CE Radiat Oncol Investig; 1999; 7(3):153-7. PubMed ID: 10406056 [TBL] [Abstract][Full Text] [Related]
12. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo. Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001 [TBL] [Abstract][Full Text] [Related]
13. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin. Chen G; Zeller WJ; Todorov DK Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496 [TBL] [Abstract][Full Text] [Related]
14. Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells. Beketic-Oreskovic L; Osmak M Cancer Chemother Pharmacol; 1995; 35(4):327-33. PubMed ID: 7828276 [TBL] [Abstract][Full Text] [Related]
15. Altered cell-cell adhesion in cisplatin-resistant human carcinoma cells: a link between beta-catenin/plakoglobin ratio and cisplatin resistance. Cimbora-Zovko T; Ambriović-Ristov A; Loncarek J; Osmak M Eur J Pharmacol; 2007 Mar; 558(1-3):27-36. PubMed ID: 17234182 [TBL] [Abstract][Full Text] [Related]
16. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells. Raaphorst GP; Miao J; Ng CE Anticancer Res; 1997; 17(5A):3469-72. PubMed ID: 9413189 [TBL] [Abstract][Full Text] [Related]
17. Effect of heat-drug sequences on thermoenhancement and uptake of cis-DDP in human pharyngeal carcinoma. Ohtsubo T; Saito H; Tanaka N; Noda I; Saito T; Kano E Anticancer Res; 1996; 16(1):297-300. PubMed ID: 8615624 [TBL] [Abstract][Full Text] [Related]
18. Induction of heat shock protein 70 in drug-resistant cells by anticancer drugs and hyperthermia. Brozovic A; Simaga S; Osmak M Neoplasma; 2001; 48(2):99-103. PubMed ID: 11478701 [TBL] [Abstract][Full Text] [Related]
19. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells. Wallner KE; Banda M; Li GC Cancer Res; 1987 Mar; 47(5):1308-12. PubMed ID: 3102043 [TBL] [Abstract][Full Text] [Related]
20. Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake. Shen DW; Goldenberg S; Pastan I; Gottesman MM J Cell Physiol; 2000 Apr; 183(1):108-16. PubMed ID: 10699972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]